Efficacy and Safety of Qizhitongluo Capsule in the Recovery Phase of Ischemic Stroke


Phase 4 Results N/A

Summary of Purpose

This is a 20-week study consisting of a 12-week multicenter, randomized,double-blind adaptive study to compare efficacy and safety of Qizhitongluo Capsule,Naoxintong Capsule and placebo in the recovery phase of ischemic stroke with qi deficiency and blood stasis syndrome, and a 8-week post-treatment safety follow-up.After 312 patients complete 12 weeks of treatment there will be an interim analysis.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 11 October 2016.

1 Oct 2013 4 Jan 2013 1 Oct 2016 1 Oct 2016 1 Oct 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment


See All